Algalr Nutrapharms Profile
Key Indicators
- Authorised Capital ₹ 1.15 Cr
- Paid Up Capital ₹ 1.15 Cr
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.50 Cr
- Revenue Growth 177.00%
- Profit Growth -17.58%
- Ebitda -5.63%
- Net Worth -52.82%
- Total Assets 19.11%
About Algalr Nutrapharms
Algalr Nutrapharms Private Limited (ANPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 July 2014 and has a history of Ten years and six months. Its registered office is in Thanjavur, Tamil Nadu, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.15 Cr and a paid-up capital of Rs 1.15 Cr.
The company has closed loans amounting to ₹1.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mohan Subramanian, Pinakin Parikh, and Krishna Daulat serve as directors at the Company.
Company Details
-
Location
Thanjavur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74900TN2014PTC096649
-
Company No.
096649
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jul 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Algalr Nutrapharms Private Limited offer?
Algalr Nutrapharms Private Limited offers a wide range of products and services, including Fish Oil, Omega 3 Fish Oil, Flavours & Aromatics, Food Additive, Petroleum and Petrochemical Products, Biofuel, Edible Oil & Allied Products, Cooking Oil, Docosahexaenoic Acid, Dietary Supplements.
Who are the key members and board of directors at Algalr Nutrapharms?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Subramanian
|
Managing Director | 24-Jul-2014 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Pinakin Parikh
|
Director | 25-May-2022 | Current |
|
Krishna Daulat
|
Director | 21-Jan-2023 | Current |
Financial Performance of Algalr Nutrapharms.
Algalr Nutrapharms Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 177% increase. The company also saw a substantial fall in profitability, with a 17.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 52.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Algalr Nutrapharms?
In 2023, Algalr Nutrapharms had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹1.50 Cr
Charges Breakdown by Lending Institutions
- Small Industries Development Bank Of India : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2016 | Small Industries Development Bank Of India | ₹1.50 Cr | Satisfied |
How Many Employees Work at Algalr Nutrapharms?
Algalr Nutrapharms has a workforce of 23 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Algalr Nutrapharms, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Algalr Nutrapharms's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
